Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation

Cytomegalovirus (CMV) infection is common following allogeneic hematopoietic stem cell transplant (HSCT) and is a major cause of morbidity and increased mortality. Whilst pharmacotherapy can be effective in the prevention and treatment of CMV, these agents are often expensive, toxic and in some case...

Full description

Bibliographic Details
Main Authors: Manar S. Shafat, Vedika Mehra, Karl S. Peggs, Claire Roddie
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Immunology
Subjects:
cytomegalovirus
virus-specific T cells
cellular therapies
antiviral therapy
infection
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01694/full

Similar Items

Similar Items